title: Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy.
authors.forename: Amer
authors.initials: A
authors.lastname: Zeidan
authors.forename: Ronald
authors.initials: R
authors.lastname: Sham
authors.forename: Joel
authors.initials: J
authors.lastname: Shapiro
authors.forename: Anthony
authors.initials: A
authors.lastname: Baratta
authors.forename: Peter
authors.initials: P
authors.lastname: Kouides
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D000069285:Infliximab; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000175:diagnosis; D016399:Lymphoma, T-Cell / Q000139:chemically induced* / Q000175:diagnosis; D013160:Splenic Neoplasms / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000911:Antibodies, Monoclonal; D000069285:Infliximab